These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38931356)

  • 1. Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years.
    Haller J
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant treatment for postnatal depression.
    Molyneaux E; Howard LM; McGeown HR; Karia AM; Trevillion K
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002018. PubMed ID: 25211400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
    Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapies for cannabis dependence.
    Marshall K; Gowing L; Ali R; Le Foll B
    Cochrane Database Syst Rev; 2014; 12(12):CD008940. PubMed ID: 25515775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of medical students' and professionals' attitudes and knowledge regarding medical cannabis.
    Weisman JM; Rodríguez M
    J Cannabis Res; 2021 Oct; 3(1):47. PubMed ID: 34641976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
    Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
    Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perception and practices regarding cannabis consumption in Karachi, Pakistan: A cross-sectional study.
    Hasan SS; Shaikh A; Ochani RK; Ashrafi MM; Ansari ZN; Abbas SH; Abbasi MK; Ashraf MA; Ali W
    J Ethn Subst Abuse; 2021; 20(3):471-489. PubMed ID: 31566085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years.
    Hosseini S; Oremus M
    Can J Psychiatry; 2019 May; 64(5):304-312. PubMed ID: 30373388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expectancies for Cannabis- Induced Emotional Breakthrough, Mystical Experiences and Changes in Dysfunctional Attitudes: Perceptions of the Potential for Cannabis-Assisted Psychotherapy for Depression.
    Earleywine M; Mian MN; Altman BR; De Leo JA
    Cannabis; 2022; 5(2):16-27. PubMed ID: 37287954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of lifetime e-cigarette and/or tobacco use and last year cannabis use among university students: A cross-sectional secondary analysis of a national survey.
    Sangster-Carrasco L; Blitchtein-Winicki D
    PLOS Glob Public Health; 2022; 2(5):e0000452. PubMed ID: 36962355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate.
    Chan GCK; Hall W; Freeman TP; Ferris J; Kelly AB; Winstock A
    Drug Alcohol Depend; 2017 Sep; 178():32-38. PubMed ID: 28624604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapies for cannabis dependence.
    Nielsen S; Gowing L; Sabioni P; Le Foll B
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD008940. PubMed ID: 30687936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.